Ilika plc (LON:IKA) has announced a significant advancement in its development of solid-state battery (SSB) technology. Its Stereax® production equipment, now fully operational at Cirtec Medical’s facility in Lowell, Massachusetts, has passed rigorous User Acceptance Tests (UATs). This achievement signifies that Ilika and Cirtec are confident the manufacturing infrastructure meets all requirements to commence production.
The production of Stereax batteries has already started, initially focused on internal process qualification, with plans to ship to the first 21 customers in the near future. This milestone marks an important step towards commercial sales, a transformative event anticipated to occur this year.
John-Marc Bunce, Director of Research at Cavendish, highlighted the significance of this development:
“Getting to the SOP with a licensee is a major milestone for this SSB technology. The next step of a validated product sale through Cirtec is not far away now, and this will be viewed as a major and transformative commercial milestone for Ilika.”
